SLCO1B1 and myopathy: Sensitivity analysis of discovery cases (all myopathy) for simvastatin cases only (Figure S3 and Table S4) showed no genomewide significant association signals (P > 5 × 10−8), although SLCO1B1 was among the top associated loci.